Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: AKT1S1

Gene summary for AKT1S1

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

AKT1S1

Gene ID

84335

Gene nameAKT1 substrate 1
Gene AliasLobe
Cytomap19q13.33
Gene Typeprotein-coding
GO ID

GO:0001932

UniProtAcc

A0A024QZF6


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
84335AKT1S1HTA11_3410_2000001011HumanColorectumAD2.29e-051.33e-010.0155
84335AKT1S1HTA11_2487_2000001011HumanColorectumSER2.03e-062.24e-01-0.1808
84335AKT1S1HTA11_1938_2000001011HumanColorectumAD3.43e-082.43e-01-0.0811
84335AKT1S1HTA11_78_2000001011HumanColorectumAD1.84e-031.45e-01-0.1088
84335AKT1S1HTA11_347_2000001011HumanColorectumAD2.93e-132.74e-01-0.1954
84335AKT1S1HTA11_2112_2000001011HumanColorectumSER1.90e-022.44e-01-0.2196
84335AKT1S1HTA11_3361_2000001011HumanColorectumAD1.34e-031.69e-01-0.1207
84335AKT1S1HTA11_83_2000001011HumanColorectumSER7.35e-062.31e-01-0.1526
84335AKT1S1HTA11_696_2000001011HumanColorectumAD9.32e-102.13e-01-0.1464
84335AKT1S1HTA11_866_2000001011HumanColorectumAD4.25e-051.27e-01-0.1001
84335AKT1S1HTA11_1391_2000001011HumanColorectumAD5.72e-122.80e-01-0.059
84335AKT1S1HTA11_2992_2000001011HumanColorectumSER1.29e-032.14e-01-0.1706
84335AKT1S1HTA11_866_3004761011HumanColorectumAD2.32e-061.89e-010.096
84335AKT1S1HTA11_7663_2000001011HumanColorectumSER6.81e-042.58e-010.0131
84335AKT1S1HTA11_10623_2000001011HumanColorectumAD1.36e-031.87e-01-0.0177
84335AKT1S1HTA11_6801_2000001011HumanColorectumSER1.64e-053.00e-010.0171
84335AKT1S1HTA11_10711_2000001011HumanColorectumAD4.64e-041.64e-010.0338
84335AKT1S1HTA11_7696_3000711011HumanColorectumAD3.19e-142.65e-010.0674
84335AKT1S1HTA11_6818_2000001011HumanColorectumAD6.25e-062.38e-010.0112
84335AKT1S1HTA11_7469_2000001011HumanColorectumAD1.45e-043.33e-01-0.0124
Page: 1 2 3 4 5 6 7 8 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
SkinThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AK: Actinic keratosis
cSCC: Cutaneous squamous cell carcinoma
SCCIS:squamous cell carcinoma in situ
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:0032535ColorectumADregulation of cellular component size142/3918383/187231.74e-133.41e-11142
GO:0070997ColorectumADneuron death114/3918361/187231.13e-063.72e-05114
GO:0010563ColorectumADnegative regulation of phosphorus metabolic process130/3918442/187231.26e-052.76e-04130
GO:1901214ColorectumADregulation of neuron death99/3918319/187231.26e-052.76e-0499
GO:0045936ColorectumADnegative regulation of phosphate metabolic process129/3918441/187231.81e-053.76e-04129
GO:0051348ColorectumADnegative regulation of transferase activity85/3918268/187232.07e-054.19e-0485
GO:0042326ColorectumADnegative regulation of phosphorylation112/3918385/187238.02e-051.27e-03112
GO:0051402ColorectumADneuron apoptotic process77/3918246/187238.07e-051.28e-0377
GO:0001933ColorectumADnegative regulation of protein phosphorylation101/3918342/187239.39e-051.42e-03101
GO:0006469ColorectumADnegative regulation of protein kinase activity65/3918212/187235.21e-045.62e-0365
GO:0033673ColorectumADnegative regulation of kinase activity71/3918237/187236.18e-046.47e-0371
GO:0043523ColorectumADregulation of neuron apoptotic process64/3918212/187238.95e-048.63e-0364
GO:0008361ColorectumADregulation of cell size56/3918181/187239.61e-049.07e-0356
GO:00325351ColorectumSERregulation of cellular component size115/2897383/187233.04e-131.10e-10115
GO:00513481ColorectumSERnegative regulation of transferase activity70/2897268/187234.27e-061.62e-0470
GO:00105631ColorectumSERnegative regulation of phosphorus metabolic process101/2897442/187232.39e-056.70e-04101
GO:00459361ColorectumSERnegative regulation of phosphate metabolic process100/2897441/187233.62e-059.39e-04100
GO:00709971ColorectumSERneuron death84/2897361/187235.76e-051.35e-0384
GO:00019331ColorectumSERnegative regulation of protein phosphorylation79/2897342/187231.21e-042.49e-0379
GO:00514021ColorectumSERneuron apoptotic process60/2897246/187231.65e-043.13e-0360
Page: 1 2 3 4 5 6 7 8 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
hsa04714ColorectumADThermogenesis120/2092232/84652.76e-191.16e-177.37e-18120
hsa05131ColorectumADShigellosis109/2092247/84651.09e-112.44e-101.55e-10109
hsa04152ColorectumADAMPK signaling pathway47/2092121/84653.74e-042.82e-031.80e-0347
hsa04213ColorectumADLongevity regulating pathway - multiple species27/209262/84658.72e-045.96e-033.80e-0327
hsa04211ColorectumADLongevity regulating pathway33/209289/84656.15e-032.68e-021.71e-0233
hsa047141ColorectumADThermogenesis120/2092232/84652.76e-191.16e-177.37e-18120
hsa051311ColorectumADShigellosis109/2092247/84651.09e-112.44e-101.55e-10109
hsa041521ColorectumADAMPK signaling pathway47/2092121/84653.74e-042.82e-031.80e-0347
hsa042131ColorectumADLongevity regulating pathway - multiple species27/209262/84658.72e-045.96e-033.80e-0327
hsa042111ColorectumADLongevity regulating pathway33/209289/84656.15e-032.68e-021.71e-0233
hsa047142ColorectumSERThermogenesis106/1580232/84651.15e-216.34e-204.61e-20106
hsa051312ColorectumSERShigellosis87/1580247/84653.07e-107.27e-095.28e-0987
hsa041402ColorectumSERAutophagy - animal39/1580141/84655.43e-033.28e-022.38e-0239
hsa042132ColorectumSERLongevity regulating pathway - multiple species20/158062/84657.15e-033.77e-022.74e-0220
hsa047143ColorectumSERThermogenesis106/1580232/84651.15e-216.34e-204.61e-20106
hsa051313ColorectumSERShigellosis87/1580247/84653.07e-107.27e-095.28e-0987
hsa041403ColorectumSERAutophagy - animal39/1580141/84655.43e-033.28e-022.38e-0239
hsa042133ColorectumSERLongevity regulating pathway - multiple species20/158062/84657.15e-033.77e-022.74e-0220
hsa047144ColorectumMSSThermogenesis113/1875232/84651.52e-194.62e-182.83e-18113
hsa051314ColorectumMSSShigellosis94/1875247/84656.82e-091.34e-078.23e-0894
Page: 1 2 3 4 5 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
AKT1S1SNVMissense_Mutationnovelc.668N>Tp.Ser223Leup.S223LQ96B36protein_codingtolerated(0.09)probably_damaging(0.978)TCGA-C5-A8XH-01Cervixcervical & endocervical cancerFemale<65I/IIUnknownUnknownSD
AKT1S1SNVMissense_Mutationc.305N>Ap.Pro102Glnp.P102QQ96B36protein_codingtolerated(0.42)possibly_damaging(0.881)TCGA-FU-A57G-01Cervixcervical & endocervical cancerFemale<65I/IIUnknownUnknownSD
AKT1S1SNVMissense_Mutationrs374227857c.661N>Tp.Arg221Trpp.R221WQ96B36protein_codingdeleterious(0.01)probably_damaging(0.953)TCGA-UC-A7PF-01Cervixcervical & endocervical cancerFemale<65I/IIUnknownUnknownSD
AKT1S1SNVMissense_Mutationnovelc.548G>Cp.Gly183Alap.G183AQ96B36protein_codingtolerated(0.38)benign(0.003)TCGA-AA-3672-01Colorectumcolon adenocarcinomaFemale>=65III/IVUnknownUnknownSD
AKT1S1SNVMissense_Mutationc.337N>Ap.Pro113Thrp.P113TQ96B36protein_codingtolerated(0.13)benign(0.06)TCGA-AA-3710-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
AKT1S1SNVMissense_Mutationrs375398248c.233C>Tp.Ala78Valp.A78VQ96B36protein_codingtolerated(0.22)benign(0.14)TCGA-AD-5900-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownSD
AKT1S1SNVMissense_Mutationrs142575650c.659N>Tp.Ala220Valp.A220VQ96B36protein_codingtolerated(0.15)benign(0.086)TCGA-AD-6889-01Colorectumcolon adenocarcinomaMale>=65I/IIChemotherapyxelodaPD
AKT1S1SNVMissense_Mutationnovelc.335N>Tp.Ser112Ilep.S112IQ96B36protein_codingdeleterious(0.01)possibly_damaging(0.737)TCGA-F4-6856-01Colorectumcolon adenocarcinomaMale<65I/IIAncillaryleucovorinCR
AKT1S1SNVMissense_Mutationnovelc.474N>Tp.Gln158Hisp.Q158HQ96B36protein_codingdeleterious(0.03)possibly_damaging(0.555)TCGA-A5-A1OF-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnknownUnknownSD
AKT1S1SNVMissense_Mutationnovelc.221T>Cp.Leu74Prop.L74PQ96B36protein_codingdeleterious(0.04)probably_damaging(0.998)TCGA-AP-A1DK-01Endometriumuterine corpus endometrioid carcinomaFemale<65I/IIUnknownUnknownSD
Page: 1 2 3 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
84335AKT1S1KINASE, DRUGGABLE GENOMEGEDATOLISIBGEDATOLISIB20166697
84335AKT1S1KINASE, DRUGGABLE GENOMEinhibitorOSI-027OSI-027
84335AKT1S1KINASE, DRUGGABLE GENOMEinhibitorAZD8055AZD-8055
84335AKT1S1KINASE, DRUGGABLE GENOMEinhibitorMLN0128SAPANISERTIB
Page: 1